iRhythm Technologies $45M Securities Class Action Settlement

iRhythm Technologies $45M Securities Class Action SettlementInvestors who bought iRhythm Technologies stock between July 25, 2022, and Aug. 9, 2024, may be eligible to claim cash from a class action settlement.iRhythm Technologies $45M Securities Class Action SettlementWeekly NewsletterClass actions settlements delivered to your inbox.Thank you! Check your inbox for a welcome email.Oops! Something went wrong while submitting the form.William C. GendronEditor in ChiefPublishedAugust 3, 2026 11:45 AMUpdatedAugust 24, 2026Join the DiscussionInvestors who purchased or otherwise acquired iRhythm Technologies Inc. common stock between July 25, 2022, and Aug. 9, 2024, may be eligible to claim a cash payment from a class action settlement.iRhythm Technologies Inc. and its chief executive officer agreed to pay $45 million to settle a securities class action lawsuit alleging they made materially false and misleading statements about the company's Zio AT heart monitoring device. The lawsuit claimed the statements misrepresented the device's near real-time data transmission capabilities, its appropriateness for high-risk patients and the accuracy of the data it reported.Who can file a claim?The settlement class includes all persons and entities who purchased or otherwise acquired iRhythm Technologies Inc. common stock between July 25, 2022, and Aug. 9, 2024, inclusive, and suffered damages as a result.Additional detailsBoth individuals and entities can be class members.The settlement includes investors who held stock in their own name and those who held through a broker or other nominee.The beneficial owner, not the record owner, must sign the claim form.Joint owners must each sign the claim form.Agents, executors, administrators, guardians and trustees may submit claims on behalf of others and must provide proof of authority.Each separate legal entity or separately managed account must submit a separate claim.